期刊文献+

血清脂蛋白(a)和胱抑素C与2型糖尿病及微血管并发症的临床研究 被引量:1

Clinical study of serum lipoprotein(a) and cystatin C with type 2 diabetes mellitus and microvascular complications
原文传递
导出
摘要 目的分析血清脂蛋白(a)[Lp(a)]和胱抑素C(Cys-C)在2型糖尿病(T2DM)以及微血管并发症患者中的变化,探讨其与T2DM及微血管并发症之间的关系。方法分别测定各组糖化血红蛋白(Hb A1c)、低密度脂蛋白(LDL)、尿素氮(BUN)、血肌酐(SCr)、Lp(a)和Cys-C水平,比较其与微血管并发症的关系。结果 T2DM患者的血清Lp(a)和Cys-C水平升高,差异有统计学意义(P<0.05)。与无微血管病变的T2DM组相比,DR组和DPN组血清Lp(a)水平升高,而DN组血清Lp(a)和Cys-C水平均升高,并且随着尿白蛋白排泄率(UAER)的升高,血清Lp(a)、Cys-C水平逐渐升高,差异均有统计学意义(P<0.05)。Logistic回归分析显示,高水平的Lp(a)是2型糖尿病患者发生糖尿病肾病的危险因素。结论血清Lp(a)和Cys-C与2型糖尿病及微血管并发症具有相关性,Lp(a)在糖尿病肾病的早期就发生改变,同时检测血清Lp(a)和Cys-C对糖尿病微血管病变的早期发现有重要意义。 Objective To analyze the levels of serum lipoprotein( a) [Lp( a) ]and cystatin C( Cys-C) in type 2 diabetes mellitus( T2DM) patients,and to determine the relationship between them and diabetic microvascular complications. Methods The levels of glycosylated hemoglobin( Hb A1c),low density lipoprotein( LDL),urea nitrogen( BUN),serum creatinine( SCr),Lp( a) and Cys-C of each group were measured. The correlation between the biochemical indexes and the microvascular complications were assessed. Results The levels of Lp( a) and Cys-C in T2 DM increased significantly,and the difference was statistically significant( P 0. 05). Compared with the T2 DM without complications,the levels of Lp( a) in DR group and DPN group increased significantly,while the levels of Lp( a) and Cys-C in DN group increased. With the increase of UAER in diabetic nephropathy,Lp( a) and Cys-C levels increased,and the differences were statistically significant( P 0. 05). Logistic regression analysis showed that the high level of Lp( a) was a risk for diabetic nephropathy in T2 DM. Conclusion The levels of Lp( a) and Cys-C were correlated with T2 DM and microvascular complications,the level of Lp( a) changed in the early stage of diabetic nephropathy,so the combined detection of serum Lp( a) and Cys-C has great significance in the early diagnosis of microvascular complications in T2 DM.
出处 《中国卫生检验杂志》 CAS 2016年第5期693-696,共4页 Chinese Journal of Health Laboratory Technology
基金 陕西省科技攻关项目[2008K16-6(7)]
关键词 脂蛋白(a) 胱抑素C 2型糖尿病 微血管并发症 Lipoprotein(a) Cystatin C Type 2 diabetes mellitus Microvascular complication
  • 相关文献

参考文献4

二级参考文献62

  • 1Grubb AO. Cys-C-Properties and use as diagnostic marker. Adv Clin Chem, 2000,35:63-99.
  • 2Ni J, Fernandez MA, Danielsson L, et al. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem, 1998,273:24797-24804.
  • 3Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest, 1995,55:617 -623.
  • 4Chapman Jr HA, Reilly Jr JJ, Yee R, Grubb A. Identification of cystatin C, a cysteine proteinase inhibitor, as a major secretory product of human alveolar macrophages in vitro. Am Rev Respir Dis, 1990, 141:698 -705.
  • 5Jung K. Low-molecular-mass proteins in serum and their relationship to the glomerular filtration rate. Nephron, 1987,47 : 160 - 168.
  • 6SimonsenO, Grubb A, Thysell. The blood concentration of Cys-C (g-trace) as a measure of glomerular filtration rate. Scand J Clin Lab Invest, 1985,45:97 - 101.
  • 7Harmoinen AP, Kouri TT, Wirta OR, et al. Evaluation of plasma cystatin C as a marker for glomerular filtration rate inpatients with type 2 diabetes. Clin Nephrol, 1999, 52:363 -370.
  • 8Mussap M, Vestra MD, Fioretto P, et al. Cys-C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int, 2002, 61: 1453-1461.
  • 9Tan GD, Lewis AV, James TJ, et al. Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes. Diabetes Care, 2002, 25 : 2004 - 2009.
  • 10Christensson AG, Grubb AO, Nilsson JA, et al. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med, 2004, 256:510 -518.

共引文献6792

同被引文献6

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部